Prevalence and risk factors of low bone mineral density in Chinese patients with systemic sclerosis: A case-control study

Rheumatology (United Kingdom)

Volumn 52, Issue 2, 2013, Pages 296-303

  Mok, Chi Chiu ^a   Chan, Pak To ^a   Chan, Kar Li ^a   Ma, Kwok Man ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Body mass index; Damage; Disease severity; Osteoporosis; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC SCLEROSIS;

ABSORPTIOMETRY, PHOTON; ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; CASE-CONTROL STUDIES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; FEMUR NECK; HIP; HUMANS; LINEAR MODELS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 84873855291     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes240     Document Type: Article

References (22)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
2. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
3. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF. Life expectancy, standardized mortality ratios and causes of death of six rheumatic diseases in Hong Kong, China. Arthritis Rheum 2011;63:1182-9.
4. Hissaria P, Lester S, Hakendorf P et al. Survival in scleroderma: results from the population based south Australian register. Intern Med J 2010;41:381-90.
5. Simeón CP, Armadans L, Fonollosa V et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 2003;42:71-5.
6. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 2010;39:269-77.
7. Loucks J, Pope JE. Osteoporosis in scleroderma. Semin Arthritis Rheum 2005;34:678-82.
8. Yuen SY, Rochwerg B, Ouimet J, Pope JE. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol 2008;35:1073-8.
9. Di Munno O, Mazzantini M, Massei P et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 1995;14:407-12.
10. La Montagna G, Vatti M, Valentini G, Tirri G. Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause. Clin Rheumatol 1991;10: 18-22.
11. Frediani B, Baldi F, Falsetti P et al. Bone mineral density in patients with systemic sclerosis. Ann Rheum Dis 2004;63: 326-7.
12. Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 2006;35:384-7.
13. Sampaio-Barros PD, Costa-Paiva L, Filardi S et al. Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 2005;23:180-4.
14. Shinjo SK, Bonfá E, de Falco Caparbo V, Pereira RM. Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency. Rheumatol Int 2010;31:1075-80.
15. Neumann K, Wallace DJ, Metzger AL. Osteoporosis-less than expected in patients with scleroderma? J Rheumatol 2000;27:1822-3.
16. Carbone L, Tylavsky F, Wan J, McKown K, Cheng S. Bone mineral density in scleroderma. Rheumatology 1999;38: 371-2.
17. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
18. Looker AC, Wahner HW, Dunn WL et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468-89.
19. Clements PJ, Lachenbruch PA, Seibold JR et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
20. Clements P, Lachenbruch P, Seibold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
21. Amjadi S, Maranian P, Furst DE et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum 2009;60:2490-8.
22. Medsger TA Jr, Silman AJ, Steen VD et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159-67.